Literature DB >> 14741070

TNF-alpha inhibition for potential therapeutic modulation of SARS coronavirus infection.

Edward Tobinick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14741070     DOI： 10.1185/030079903125002757

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN： 0300-7995            Impact factor:   2.580


× No keyword cloud information.
  23 in total

Review 1.  Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation.

Authors:  Isabelle Amigues; Alexander H Pearlman; Aarat Patel; Pankti Reid; Philip C Robinson; Rashmi Sinha; Alfred Hj Kim; Taryn Youngstein; Arundathi Jayatilleke; Maximilian Konig
Journal:  Expert Rev Clin Immunol       Date:  2020-11-25       Impact factor: 4.473

2.  Identification and Development of Therapeutics for COVID-19.

Authors:  Halie M Rando; Nils Wellhausen; Soumita Ghosh; Alexandra J Lee; Anna Ada Dattoli; Fengling Hu; James Brian Byrd; Diane N Rafizadeh; Ronan Lordan; Yanjun Qi; Yuchen Sun; Christian Brueffer; Jeffrey M Field; Marouen Ben Guebila; Nafisa M Jadavji; Ashwin N Skelly; Bharath Ramsundar; Jinhui Wang; Rishi Raj Goel; YoSon Park; Simina M Boca; Anthony Gitter; Casey S Greene
Journal:  mSystems       Date:  2021-11-02       Impact factor: 6.496

3.  Two Genetically Similar H9N2 Influenza A Viruses Show Different Pathogenicity in Mice.

Authors:  Qingtao Liu; Yuzhuo Liu; Jing Yang; Xinmei Huang; Kaikai Han; Dongmin Zhao; Keran Bi; Yin Li
Journal:  Front Microbiol       Date:  2016-11-04       Impact factor: 5.640

4.  Can Colchicine as an Old Anti-Inflammatory Agent Be Effective in COVID-19?

Authors:  Somayyeh Nasiripour; Farhad Zamani; Maryam Farasatinasab
Journal:  J Clin Pharmacol       Date:  2020-05-23       Impact factor: 3.126

Review 5.  Treatment of severe acute respiratory syndrome.

Authors:  S T Lai
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-09       Impact factor: 3.267

6.  High Inflammatory Burden: A Potential Cause of Myocardial Injury in Critically Ill Patients With COVID-19.

Authors:  Yanjun Song; Peng Gao; Tian Ran; Hao Qian; Fan Guo; Long Chang; Wei Wu; Shuyang Zhang
Journal:  Front Cardiovasc Med       Date:  2020-07-07

7.  Non-complicated evolution of COVID-19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab.

Authors:  Mario Valenti; Paola Facheris; Giulia Pavia; Luigi Gargiulo; Riccardo Giovanni Borroni; Antonio Costanzo; Alessandra Narcisi
Journal:  Dermatol Ther       Date:  2020-06-26       Impact factor: 3.858

Review 8.  COVID-19 revisiting inflammatory pathways of arthritis.

Authors:  Georg Schett; Bernhard Manger; David Simon; Roberto Caporali
Journal:  Nat Rev Rheumatol       Date:  2020-06-19       Impact factor: 20.543

Review 9.  The trinity of COVID-19: immunity, inflammation and intervention.

Authors:  Matthew Zirui Tay; Chek Meng Poh; Laurent Rénia; Paul A MacAry; Lisa F P Ng
Journal:  Nat Rev Immunol       Date:  2020-04-28       Impact factor: 108.555

Review 10.  Utility and risk of dermatologic medications during the COVID-19 pandemic.

Authors:  Mohamad Goldust; Karin Hartmann; Ayman Abdelmaksoud; Alexander A Navarini
Journal:  Dermatol Ther       Date:  2020-08-05       Impact factor: 3.858
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.